Clinical Updates
Drug approvals, guideline changes, and treatment advances
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Clinical Updates
Bolton Medical Recalls Relay Pro Thoracic Stent Grafts Over Deployment Failure Risk
Bolton Medical has recalled its Relay Pro thoracic stent graft system worldwide after reports of…
UK tightens oversight of high-street health self-tests after BMJ finds safety gaps
The UK's medicines regulator is planning stricter oversight of high-street health self-tests following a BMJ…
New guidance on advanced therapy clinical trials: What researchers need to know
The Danish Medicines Agency has published new standardized guidance on Investigator's Brochures for advanced therapy…
FDA Issues Correction Notice for TRUE METRIX Blood Glucose Monitors Over Error Code Risk
Trividia Health has issued a correction notice for TRUE METRIX blood glucose monitors after reports…
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight…